UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 5, 2004
-------------
BIO-IMAGING TECHNOLOGIES, INC.
------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware 1-11182 11-2872047
--------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification No.)
826 Newtown-Yardley Road, Newtown, Pennsylvania 18940
--------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(267) 757-3000
--------------
(Registrant's telephone number,
including area code)
------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits.
Exhibit No. Description of Exhibit
----------- ----------------------
99.1 Press release dated May 5, 2004.
ITEM 12. DISCLOSURE OF RESULTS OF OPERATIONS AND FINANCIAL CONDITION.
On May 5, 2004, Bio-Imaging Technologies, Inc. (the "Company") announced
its financial results for the first quarter ended March 31, 2004. The full text
of the press release issued in connection with the announcement is attached as
Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Form 8-K and the Exhibit attached hereto is being
furnished under "Item 12. Disclosure of Results of Operations and Financial
Condition." The information shall not be deemed "filed" for purposes of Section
18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
- 2 -
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BIO-IMAGING TECHNOLOGIES, INC.
Dated: May 5, 2004 By: /s/ Mark L. Weinstein
--------------------------------------------
Name: Mark L. Weinstein
Title: President and Chief Executive Officer
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press release dated May 5, 2004.